Crossmark

Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents

Crossref DOI link: https://doi.org/10.1016/j.aohep.2023.101182

Published Print: 2024-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Maldonado-Rojas, Andrea del Carmen

Zuarth-Vázquez, Julia María

Uribe, Misael

Barbero-Becerra, Varenka J
License Information

Text and Data Mining valid from 2024-03-01

Text and Data Mining valid from 2024-03-01

Version of Record valid from 2023-11-20
More Information

This article is maintained by: Elsevier

Article Title: Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2023.101182

Content Type: article

Copyright: © 2023 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.